Fairmount Funds Management LLC 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-13 06:06 am Purchase | 2024-06-11 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 11,330,141 9.900% | 1,343,585 (+13.45%) | Filing |
| 2024-04-01 6:30 pm Sale | 2024-03-28 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 9,986,556 9.900% | -31,519 (-0.31%) | Filing |
| 2024-03-27 4:37 pm Sale | 2024-03-25 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 10,018,075 9.900% | -13,061,066 (-56.59%) | Filing |
| 2024-02-16 6:55 pm Purchase | 2024-02-16 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 23,079,141 18.890% | 3,116,577 (+15.61%) | Filing |
| 2023-06-13 4:06 pm Purchase | 2023-06-09 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 19,962,564 19.990% | 4,732,091 (+31.07%) | Filing |
| 2022-06-21 10:04 am Purchase | 2022-06-16 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 15,230,473 19.990% | 15,230,473 (New Position) | Filing |